IDO1 and neoplasm: In contrast, when Ido1 was knocked out from the tumor cells (4T1Ido1-KO), the activity of STING-NP monotherapy was recovered, showing similar tumor growth inhibition to iBINP treatment (Figure 6N and Supplemental Figure 6I).